Kateryna Dunayenko

Title: Kateryna Dunayenko: Innovator in Therapeutic Compounds

Introduction

Kateryna Dunayenko is a prominent inventor based in Kyiv, Ukraine. She has made significant contributions to the field of therapeutic compounds, particularly in the area of androgen receptor modulation. Her innovative work has the potential to impact various medical conditions.

Latest Patents

Kateryna holds a patent for "Human androgen receptor DNA-binding domain (DBD) compounds as therapeutics and methods for their use." This patent describes a compound with a specific structure that includes substituted or unsubstituted aryl or heteroaryl groups. The compounds are designed for the treatment of androgen-modulated indications, including various types of cancer, hair loss, acne, hirsutism, ovarian cysts, polycystic ovary disease, precocious puberty, and age-related macular degeneration. The patent also outlines the use of these compounds in the manufacture of medicaments for modulating androgen receptor activity.

Career Highlights

Kateryna is affiliated with the University of British Columbia, where she continues her research and development in therapeutic innovations. Her work is characterized by a strong focus on the practical applications of her inventions in the medical field.

Collaborations

Some of her notable coworkers include Artem Tcherkassov and Paul Rennie, who contribute to her research endeavors and collaborative projects.

Conclusion

Kateryna Dunayenko's contributions to the field of therapeutic compounds highlight her role as an innovative inventor. Her work has the potential to lead to significant advancements in the treatment of various medical conditions.